Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2010
11/25/2010US20100297730 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
11/25/2010US20100297729 Process for producing transglutaminase
11/25/2010US20100297728 Random-Primed Transcriptase -In Vitro Transcription Method for RNA Amplification
11/25/2010US20100297723 Heat-stable carbonic anhydrases and their use
11/25/2010US20100297722 Transgenic moss producing terpenoids
11/25/2010US20100297721 Gene knockout mesophilic and thermophilic organisms, and methods of use thereof
11/25/2010US20100297713 Mutant delta-8 desaturase genes engineered by targeted mutagenesis and their use in making polyunsaturated fatty acids
11/25/2010US20100297706 Mutant dna polymerases and their genes from thermococcus
11/25/2010US20100297700 Antibodies to TNF Alpha
11/25/2010US20100297699 Nucleic Acids Encoding Humanized Immunoglobulin That Binds Alpha4Beta7 Integrin
11/25/2010US20100297698 System and method for producing synthetic microorganisms capable of translating proteins containing non-standard amino acids
11/25/2010US20100297697 Methods for increasing protein titers
11/25/2010US20100297695 Nucleic Acids Encoding Chimeric CD154 Polypeptides
11/25/2010US20100297694 Novel gene from hancenula polymorpha capable of controlling unfolded protein response and method for increasing effect of secretion using the same
11/25/2010US20100297664 Paratope and epitope of anti-mortalin antibody
11/25/2010US20100297662 Antibody and use thereof
11/25/2010US20100297650 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
11/25/2010US20100297643 Terminus-Specific DNA Modification Using Random-Sequence Template Oligonucleotides
11/25/2010US20100297641 Methylation altered dna sequences as markers associated with human cancer
11/25/2010US20100297620 Activated protease indicator
11/25/2010US20100297613 Nucleic acid, amino acid encoded by said nucleic acid, probe comprising said nucleic acid or said amino acid, and screening method using said probe
11/25/2010US20100297606 IgG BINDING PEPTIDE
11/25/2010US20100297219 Methods and Compositions for Modifying Apolipoprotein B mRNA Editing
11/25/2010US20100297185 Mycobacterial mutants affecting host apoptosis
11/25/2010US20100297184 Vaccines
11/25/2010US20100297183 Immunogenic streptococcus proteins
11/25/2010US20100297178 Novel genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
11/25/2010US20100297175 Mutations in a toll-like receptor motif in the NS4B of classical swine fever virus strain brescia influences virulence in swine
11/25/2010US20100297171 Development of a preventive vaccine for filovirus infection in primates
11/25/2010US20100297169 Novel Neutralizing Immunogen (NIMIV) of Rhinovirus and its Use for Vaccine Applications
11/25/2010US20100297167 Method for the Production of Recombinant Virus, DNA Constructs, Recombinant Virus and Vaccine Compositions
11/25/2010US20100297162 S. epidermidis antigens
11/25/2010US20100297153 Binding molecules for treatment and detection of cancer
11/25/2010US20100297152 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
11/25/2010US20100297151 Antibodies against human il-21 receptor and uses therefor
11/25/2010US20100297149 Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities
11/25/2010US20100297138 Human monoclonal antibodies to fucosyl-gm1 and methods for using anti-fucosyl-gm1
11/25/2010US20100297136 Gastric and Prostate Cancer Associated Antigens
11/25/2010US20100297131 Binding domain of plasmodium reticulocyte binding proteins
11/25/2010US20100297130 Protective anti-glucan antibodies with preference for beta-1,3-glucans
11/25/2010US20100297119 Bone targeted alkaline phosphatase, kits and methods of use thereof
11/25/2010US20100297114 Antigen presenting cell targeted vaccines
11/25/2010US20100297109 Methods for inhibiting fascin
11/25/2010US20100297105 Administering antisense oligonucleotides complementary to human apolipoprotein b
11/25/2010US20100297103 Antibody having enhanced adcc activity and method for production thereof
11/25/2010US20100297101 Integrin alpha. II .B.beta.3 Specific Antibodies and Peptides
11/25/2010US20100297091 Compositions and methods for treatment of melanomas
11/25/2010US20100297085 Synthetic Herpes Simplex Viruses Type-1 for Treatment of Cancers
11/25/2010US20100297084 method for transducing cells with primary cilia
11/25/2010US20100297083 Polynucleotides and Polypeptide of Human KV1.3, Compositions Comprising Same and Methods of Using Same
11/25/2010US20100297080 Genetic markers associated with interferon-alpha response
11/25/2010US20100297071 Immune response inducer
11/25/2010US20100297064 Cytokine zalpha11 ligand antibodies
11/25/2010US20100297063 Cytokine zalpha11 ligand antibodies
11/25/2010US20100297060 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents
11/25/2010US20100297024 Promoter inducible by reactive oxygen species and vector comprising the same
11/25/2010US20100297023 Lipid
11/25/2010US20100297022 Magnetosome Gene Expression in Eukaryotic Cells
11/25/2010US20100297011 Isolated peptides and uses thereof
11/25/2010US20100297010 Tumor suppressor gene screening using rna interference libraries and method of treatment
11/25/2010US20100297008 Ganglioside associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumors
11/25/2010US20100297004 High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection
11/25/2010US20100297003 Anti-human tenascin monoclonal antibody
11/25/2010DE112008002848T5 Pflanzen mit verbesserten Ertragsmerkmalen und Verfahren zu ihrer Herstellung Plants having enhanced yield characteristics and methods for their preparation
11/25/2010DE102009022772A1 Mikroorganismus zur Expression eines humanen Membranproteins Microorganism for expression of a human membrane protein
11/25/2010CA2764931A1 Engineered type iv pilin of clostridium difficile
11/25/2010CA2763283A1 Phytases, nucleic acids encoding them and methods for making and using them
11/25/2010CA2763156A1 Identification of micro-rnas involved in post-myocardial infarction remodeling and heart failure
11/25/2010CA2763016A1 Targeting micrornas for metabolic disorders
11/25/2010CA2762987A1 Treatment of transcription factor e3 (tfe3) and insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antisense transcript to tfe3
11/25/2010CA2762813A1 Use of inhibitors of zdhhc2 activity for modulation of adipogenesis
11/25/2010CA2762802A1 Reverse genetics using non-endogenous pol i promoters
11/25/2010CA2762604A1 Bifunctional polypeptides
11/25/2010CA2762586A1 Compositions, kits and methods for in vitro antigen presentation, assessing vaccine efficacy, and assessing immunotoxicity of biologics and drugs
11/25/2010CA2762463A1 Eukaryotic host cell comprising an expression enhancer
11/25/2010CA2762369A1 Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
11/25/2010CA2762095A1 Compositions comprising cationic amphiphiles and colipids for delivering therapeutics molecules
11/25/2010CA2761964A1 Antibiotic-free plasmid
11/25/2010CA2758581A1 Variants of c-type natriuretic peptide
11/24/2010EP2253956A2 Immune response assessment method
11/24/2010EP2253719A2 Diagnosing and monitoring transplant rejection based on marker expression levels
11/24/2010EP2253718A2 Solid surface for biomolecule delivery and high-throughput assay
11/24/2010EP2253717A1 Method of amplifying nucleic acid by using double-stranded nucleic acid as template
11/24/2010EP2253712A1 Method of distinguishing inflammatory pathogen causing acute respiratory infection
11/24/2010EP2253709A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/24/2010EP2253708A1 Suppresion of specific classes of soybean seed protein genes
11/24/2010EP2253707A2 Expec-specific proteins, genes encoding them and uses thereof
11/24/2010EP2253706A2 Antisense modulation of kinesin-like 1 expression
11/24/2010EP2253705A1 Use of inhibitors of Zdhhc2 activity for modulation of adipogenesis
11/24/2010EP2253704A1 Oligonucleotide mediated nucleic acid recombination
11/24/2010EP2253703A1 Human coagulation factor VII variants
11/24/2010EP2253702A1 High throughput assay of LP-PLA2 activity
11/24/2010EP2253646A1 Anti-dual integrin antibody and compositions and conjugates comprising said antibody
11/24/2010EP2253643A1 Novel compositions and methods in cancer associated with altered expression of PRLR
11/24/2010EP2253642A1 Polypeptides, cDNAs encoding the same and utilization thereof
11/24/2010EP2253639A1 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues
11/24/2010EP2252694A1 Regeneration and mass propagation of jatropha curcas through somatic embryogenesis
11/24/2010EP2252693A2 Method and constructs for increasing recombinant protein production in plants dehydration stress
11/24/2010EP2252692A1 A thermostable dna polymerase from palaeococcus ferrophilus
11/24/2010EP2252691A1 Method for producing alpha- santalene
1 ... 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 ... 4023